Hemorrhagic Disorders

14 clinical trials · Condition

Record	Firm	Date
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma (NCT04309084)	Celularity Incorporated	2020-05-12
Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors (NCT03734588)	Spark Therapeutics, Inc.	2019-01-30
Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants (NCT03876301)	Spark Therapeutics, Inc.	2019-01-21
Determination of Fibrin Activity in Plasma on STA-R® Prototype (NCT02856789)	Diagnostica Stago R&D	2016-08-01
Comparison of Accidents and Their Circumstances With Oral Anticoagulants (NCT02376777)	CNGE IRMG Association	2014-04-01
A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF (NCT01787552)	Novartis Pharmaceuticals	2013-05-08
Standardisation of Investigations of Mild Bleeding Disorders (NCT02329899)	University Hospital, Geneva	2012-07-01
Cooperative Study of Factor VIII Inhibitors (NCT00000582)	National Heart, Lung, and Blood Institute (NHLBI)	1978-07-01

Every clearance here is in the API, with alerts when new ones post.